Mohammed Asmal

Mohammed Asmal

Directeur Technique/Scientifique/R&D chez PRIME MEDICINE, INC.

Health Technology
Consumer Services
Finance

Profil

Mohammed Asmal, M.D., Ph.D., is a Venture Partner with OrbiMed.
Prior to joining OrbiMed, Dr. Asmal led clinical research and development in gene therapies for rare diseases at Bluebird Bio.
His prior experience has included leading clinical trials in oncology and infectious diseases at Vertex Pharmaceuticals and attending on the Infectious Disease service at Brigham and Women's Hospital.
He has published scientific articles in peer reviewed journals on HIV pathogenesis and vaccine research.
Dr. Asmal received his A.B.
degree magna cum laude in Biological Sciences and Biomedical Engineering from Harvard University and his joint M.D.-Ph.D.
from Columbia University where he was elected to the Alpha Omega Alpha Medical Honor Society.

Postes actifs de Mohammed Asmal

SociétésPosteDébut
PRIME MEDICINE, INC. Directeur Technique/Scientifique/R&D -
Tous les postes actifs de Mohammed Asmal

Anciens postes connus de Mohammed Asmal

SociétésPosteFin
BLUEBIRD BIO, INC. Directeur Technique/Scientifique/R&D 01/04/2020
Private Equity Investor -
Voir l'expérience en détail de Mohammed Asmal

Formation de Mohammed Asmal

Harvard University Undergraduate Degree
The Trustees of Columbia University in The City of New York Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Mohammed Asmal

Relations

41

Relations au 1er degré

5

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
BLUEBIRD BIO, INC.

Health Technology

PRIME MEDICINE, INC.

Health Technology

Entreprise privées1

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Mohammed Asmal